Alma Veil™
The high prevalence of vascular concerns among Americans such as diffused redness/rosacea (16 million1), angiomas (50% after the age of 302) and spider veins (60%3) underscores the importance of addressing vascular issues for optimal skin health.
Alma Veil™ effectively targets a wide range of common dermatological and vascular conditions using three best-in-class technologies seamlessly integrated into a single handpiece.
The high prevalence of vascular concerns among Americans such as diffused redness/rosacea (16 million1), angiomas (50% after the age of 302) and spider veins (60%3) underscores the importance of addressing vascular issues for optimal skin health.
Alma Veil™ effectively targets a wide range of common dermatological and vascular conditions using three best-in-class technologies seamlessly integrated into a single handpiece.
The meticulously engineered DermaCore™ Delivery modulates pulse range, ensuring effective and simultaneous targeting of larger and smaller vascular structures, and optimizing results
Treat a wide range of dermatological conditions including vascular lesions with 532 nm, deeper vascular lesions with 1064 nm, and skin quality concerns without downtime using MicroPulse™ – all with a single handpiece
The contact cooling tip on the state-of-the-art handpiece cools the skin’s surface before, during and after laser energy is emitted, offering superior cooling for safe and efficacious treatment
An all-inclusive workstation that eliminates the need for consumables such as cryogen and dyes
Proven Results
a new standard of excellence
DermaCore™ Difference
In a split-face study (N=4)4, Alma Veil’s innovative DermaCore Delivery showed superior or comparable efficacy to a competitive vascular laser, despite using lower fluence levels. DermaCore’s efficient beam targets both large and small vascular structures simultaneously, optimizing treatments and outcomes.
Superior Cooling
Unlike some vascular lasers on the market, Alma Veil offers contact cooling pre-, during and post-treatment for improved safety and patient comfort, limiting unwanted purpura.
